IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $566,000 | -46.2% | 9,369 | -46.7% | 0.00% | -50.0% |
| Q3 2019 | $1,052,000 | +55.2% | 17,565 | +66.7% | 0.01% | +60.0% |
| Q2 2019 | $678,000 | -64.0% | 10,540 | -54.6% | 0.01% | -66.7% |
| Q1 2019 | $1,883,000 | +259.4% | 23,200 | +139.4% | 0.02% | +200.0% |
| Q4 2018 | $524,000 | 0.0% | 9,690 | -4.7% | 0.01% | 0.0% |
| Q3 2018 | $524,000 | +46.8% | 10,167 | +18.7% | 0.01% | 0.0% |
| Q2 2018 | $357,000 | -8.7% | 8,562 | -3.5% | 0.01% | 0.0% |
| Q1 2018 | $391,000 | -18.2% | 8,877 | -6.7% | 0.01% | -16.7% |
| Q4 2017 | $478,000 | -5.0% | 9,512 | -4.3% | 0.01% | -25.0% |
| Q3 2017 | $503,000 | +1.6% | 9,944 | +2.2% | 0.01% | -11.1% |
| Q2 2017 | $495,000 | +36.7% | 9,733 | +7.8% | 0.01% | +28.6% |
| Q1 2017 | $362,000 | -22.0% | 9,025 | -6.7% | 0.01% | -30.0% |
| Q4 2016 | $464,000 | +11.0% | 9,670 | -15.2% | 0.01% | 0.0% |
| Q3 2016 | $418,000 | +53.1% | 11,398 | -4.0% | 0.01% | +42.9% |
| Q2 2016 | $273,000 | – | 11,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |